These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 28845483)

  • 1. Interaction of factor V B-domain acidic region with its basic region and with TFPI/TFPI2: Structural insights from molecular modeling studies.
    Vadivel K; Kumar Y; Bunce MW; Camire RM; Bajaj MS; Bajaj SP
    Int Biol Rev; 2017 May; 1(1):. PubMed ID: 28845483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of factor V and factor V-short by TFPIα: Relationship between B-domain proteolysis and binding.
    Petrillo T; Ayombil F; Van't Veer C; Camire RM
    J Biol Chem; 2021; 296():100234. PubMed ID: 33376137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelets contain tissue factor pathway inhibitor-2 derived from megakaryocytes and inhibits fibrinolysis.
    Vadivel K; Ponnuraj SM; Kumar Y; Zaiss AK; Bunce MW; Camire RM; Wu L; Evseenko D; Herschman HR; Bajaj MS; Bajaj SP
    J Biol Chem; 2014 Nov; 289(45):31647-61. PubMed ID: 25262870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoring the procofactor state of factor Va-like variants by complementation with B-domain peptides.
    Bunce MW; Bos MHA; Krishnaswamy S; Camire RM
    J Biol Chem; 2013 Oct; 288(42):30151-30160. PubMed ID: 24014022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural architecture of the acidic region of the B domain of coagulation factor V.
    Mohammed BM; Basore K; Summers B; Pelc LA; Di Cera E
    J Thromb Haemost; 2024 Mar; 22(3):709-714. PubMed ID: 38007061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TFPIα interacts with FVa and FXa to inhibit prothrombinase during the initiation of coagulation.
    Wood JP; Petersen HH; Yu B; Wu X; Hilden I; Mast AE
    Blood Adv; 2017 Dec; 1(27):2692-2702. PubMed ID: 29291252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of exosite binding modulators in the inhibition of Fxa by TFPI.
    Peraramelli S; Thomassen S; Heinzmann A; Hackeng TM; Hartmann R; Scheiflinger F; Dockal M; Rosing J
    Thromb Haemost; 2016 Mar; 115(3):580-90. PubMed ID: 26607136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and functional characterization of tissue factor pathway inhibitor following degradation by matrix metalloproteinase-8.
    Cunningham AC; Hasty KA; Enghild JJ; Mast AE
    Biochem J; 2002 Oct; 367(Pt 2):451-8. PubMed ID: 12117418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A bipartite autoinhibitory region within the B-domain suppresses function in factor V.
    Bos MH; Camire RM
    J Biol Chem; 2012 Jul; 287(31):26342-51. PubMed ID: 22707727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure and biology of tissue factor pathway inhibitor.
    Bajaj MS; Birktoft JJ; Steer SA; Bajaj SP
    Thromb Haemost; 2001 Oct; 86(4):959-72. PubMed ID: 11686353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of regions distal to glycine-160 to the anticoagulant activity of tissue factor pathway inhibitor.
    Lockett JM; Mast AE
    Biochemistry; 2002 Apr; 41(15):4989-97. PubMed ID: 11939795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimerin 1 binds factor V and activated factor V with high affinity and inhibits thrombin generation.
    Jeimy SB; Fuller N; Tasneem S; Segers K; Stafford AR; Weitz JI; Camire RM; Nicolaes GA; Hayward CP
    Thromb Haemost; 2008 Dec; 100(6):1058-67. PubMed ID: 19132231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The second Kunitz domain of human tissue factor pathway inhibitor: cloning, structure determination and interaction with factor Xa.
    Burgering MJ; Orbons LP; van der Doelen A; Mulders J; Theunissen HJ; Grootenhuis PD; Bode W; Huber R; Stubbs MT
    J Mol Biol; 1997 Jun; 269(3):395-407. PubMed ID: 9199408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlates of plasma and platelet tissue factor pathway inhibitor, factor V, and Protein S.
    Ellery PER; Hilden I; Sejling K; Loftager M; Martinez ND; Maroney SA; Mast AE
    Res Pract Thromb Haemost; 2018 Jan; 2(1):93-104. PubMed ID: 29354797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role for the Kunitz-3 domain of tissue factor pathway inhibitor-alpha in cell surface binding.
    Piro O; Broze GJ
    Circulation; 2004 Dec; 110(23):3567-72. PubMed ID: 15557366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a Plasma-Based Assay to Measure the Susceptibility of Factor V to Inhibition by the C-Terminus of TFPIα.
    van Doorn P; Rosing J; Campello E; Middeldorp S; Simioni P; Meijers JCM; Hackeng TM; Castoldi E
    Thromb Haemost; 2020 Jan; 120(1):55-64. PubMed ID: 31705518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular cloning, expression, and partial characterization of a second human tissue-factor-pathway inhibitor.
    Sprecher CA; Kisiel W; Mathewes S; Foster DC
    Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3353-7. PubMed ID: 8159751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning of the cDNA encoding mouse PP5/TFPI-2 and mapping of the gene to chromosome 6.
    Miyagi Y; Yasumitsu H; Mizushima H; Koshikawa N; Matsuda Y; Itoh H; Hori TA; Aoki I; Misugi K; Miyazaki K
    DNA Cell Biol; 1996 Nov; 15(11):947-54. PubMed ID: 8945635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural requirements for TFPI-mediated inhibition of neointimal thickening after balloon injury in the rat.
    Han X; Girard TJ; Baum P; Abendschein DR; Broze GJ
    Arterioscler Thromb Vasc Biol; 1999 Oct; 19(10):2563-7. PubMed ID: 10521388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue factor pathway inhibitor - cofactor-dependent regulation of the initiation of coagulation.
    Ahnström J; Petri A; Crawley JTB
    Curr Opin Hematol; 2024 Nov; 31(6):315-320. PubMed ID: 39259668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.